Literature DB >> 15949506

Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.

Nicola De Stefano1, Maria L Bartolozzi, Leonello Guidi, Maria L Stromillo, Antonio Federico.   

Abstract

Recent MR studies have emphasised the importance of neuronal and axonal damage in multiple sclerosis. In this respect, proton MR spectroscopy (by monitoring levels of N-acetylaspartate, a putative marker of axonal integrity) has been particularly illuminating by showing indirect evidence of neurodegeneration in both lesional and non-lesional brain tissues from the earliest stages of the disease. The importance of these changes to patients' clinical disability argues for the primary role of neuronal pathology in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15949506     DOI: 10.1016/j.jns.2005.03.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

1.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Authors:  Ivan I Kirov; Songtao Liu; Roman Fleysher; Lazar Fleysher; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

Review 2.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

3.  Natural linewidth chemical shift imaging (NL-CSI).

Authors:  Adil Bashir; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

Review 4.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 5.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

6.  Measurement of serum, liver, and brain cytokine induction, thiamine levels, and hepatopathology in rats exposed to a 4-day alcohol binge protocol.

Authors:  Natalie M Zahr; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

7.  In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage.

Authors:  Natalie M Zahr; Dirk Mayer; Shara Vinco; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

8.  A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2013-01-10       Impact factor: 7.853

9.  Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.

Authors:  Salem Hannoun; Matthieu Bagory; Francoise Durand-Dubief; Danielle Ibarrola; Jean-Christophe Comte; Christian Confavreux; Francois Cotton; Dominique Sappey-Marinier
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

10.  Quantitative electroencephalography reveals different physiological profiles between benign and remitting-relapsing multiple sclerosis patients.

Authors:  Manuel Vazquez-Marrufo; Javier J Gonzalez-Rosa; Encarnacion Vaquero; Pablo Duque; Monica Borges; Carlos Gomez; Guillermo Izquierdo
Journal:  BMC Neurol       Date:  2008-11-24       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.